Table 3.
n (%) | |
---|---|
IPF-related treatment | |
Immediately before treatment start | |
Corticosteroids | 6 (18.2%) |
N-acetylcysteine | 13 (39.4%) |
Oxygen therapy | 4 (12.1%) |
Immediately after treatment start | |
Corticosteroids | 7 (21.2%) |
N-acetylcysteine | 10 (30.3%) |
Oxygen therapy | 5 (15.2%) |
Other | 1 (3.0%) |
Gastrointestinal treatment | |
Immediately before treatment start | |
Proton-pump inhibitors | 14 (42.4%) |
Immediately after treatment start | |
Proton-pump inhibitors | 14 (42.4%) |
Other | 1 (3.0%) |